Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2002-11-13
2008-12-02
Foley, Shanon A. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S190100, C530S300000, C530S350000, C435S069100, C435S069700, C435S252300, C435S320100, C536S023400, C536S023700, C514S04400A, C514S459000
Reexamination Certificate
active
07459165
ABSTRACT:
The present invention relates to polypeptides ofPseudomonas aeruginosawhich may be used to prevent, diagnose and/or treatPseudomonas aeruginosainfection.
REFERENCES:
patent: 4338397 (1982-07-01), Gilbert et al.
patent: 4425437 (1984-01-01), Riggs
patent: 4431739 (1984-02-01), Riggs
patent: 6551795 (2003-04-01), Rubenfield et al.
patent: 0 297 291 (1993-10-01), None
patent: 0 717 106 (2000-03-01), None
patent: WO 99/57142 (1999-11-01), None
patent: WO 01/02577 (2001-01-01), None
patent: WO 01/40473 (2001-06-01), None
patent: WO 02/064161 (2002-08-01), None
Rudinger et al, in “Peptide Hormones”, edited by Parsons, J.A., University Park Press, Jun. 1976.
Burgess et al., The Journal of Cell Biology, 111:2129-2138, 1990.
Lazar et al., Molecular and Cellular Biology, 8(3): 1247-1252, 1988; Jobling et al. (Mol. Microbiol. 1991, 5(7): 1755-67).
Database: PIR—80, Accession No. F83148.
Riffkin et al 1995, Gene 167: 279-283.
Blackburn, N.T. et al., “Characterization of Soluble and Membrane-Bound Family 3 Lytic Transglycosylases fromPseudomonas aeruginosa,” Biochemistry 41:1001-1013, 2002.
Gregoriadis, G., “Immunological adjuvants: a role for liposomes,”Immunology Today 11(3):89-97, 1990.
Holder, I.A., “PseudomonaslVaccination and Immunotherapy,”J. Burn Care Rehabil. 22(5):311-320, 2001.
Jobling, M.G. et al., “Analysis of structure and function of the B subunit of cholera toxin by the use of site-directed mutagenesis,”Molecular Microbiology, 5(7):1755-1767, 1991.
Stanislavsky, E.S. et al., “,”FEMS Microbiol. Rev., 21(3):243-277, 1997.
Stover, C.K. et al., “Complete Genome Sequence ofPseudomonas aeruginosaPA01, an Opportunistic Pathogen,”Nature, Macmillan Journals Ltd., London, GB, 406(6799):959-694, Aug. 31, 2000.
Database Accession No. Q9HX28.
Database Accession No. AE004817.
Jameson and Wolf. “The antigenic index: a novel algorithm for predicting antigenic determinants,” Computer Application Bioscience, 4(1):181-186, 1988.
Wan et al., “Epitope Map for a Growth Hormone Receptor Agonist Monoclonal Antibody, MAb 263,” Molecular Endocrinology, 17(11):2240-2250, 2003.
Brodeur Bernard
Bussiere Diane
Charland Nathalie
Charlebois Isabelle
Hamel Josee
Baskar Padma v
Foley Shanon A.
ID Biomedical Corporation
Seed IP Law Group PLLC
LandOfFree
Polypeptides of Pseudomonas aeruginosa does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptides of Pseudomonas aeruginosa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptides of Pseudomonas aeruginosa will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4024314